You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Polyethylene Glycol 3350 And Electrolytes patents expire, and when can generic versions of Polyethylene Glycol 3350 And Electrolytes launch?

Polyethylene Glycol 3350 And Electrolytes is a drug marketed by Paddock Llc and Strides Pharma and is included in two NDAs.

The generic ingredient in POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
  • What are the global sales for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
  • What is Average Wholesale Price for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
Summary for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
Drug patent expirations by year for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
Recent Clinical Trials for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Leading BioSciences, IncPhase 2
Ningbo No. 1 HospitalN/A
Rajavithi HospitalPhase 4

See all POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES clinical trials

US Patents and Regulatory Information for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 090712-001 Feb 25, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 204558-001 Dec 21, 2018 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.